Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Refractory Prostate Cancer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07611110
What this trial is testing

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
AstraZeneca 670
Early research (Phase 1)Active Not RecruitingNCT07214961
What this trial is testing

Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer (CRPC)Metastatic Castrate Resistant Prostate Cancer (mCRPC)
ARTBIO Inc. 80
Testing effectiveness (Phase 2)Study completedNCT02903160
What this trial is testing

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 40
Testing effectiveness (Phase 2)UnknownNCT02049190
What this trial is testing

Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate CancerAndrogen-independent Prostate Cancer+1 more
Arno Therapeutics 75
Testing effectiveness (Phase 2)Study completedNCT00513071
What this trial is testing

AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Hormone-resistant Prostate CancerRecurrent Prostate Cancer
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Temporarily pausedNCT05361915
What this trial is testing

Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer Metastatic
Sorrento Therapeutics, Inc. 100
Early research (Phase 1)Ended earlyNCT04740034
What this trial is testing

AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 42
Not applicableEnded earlyNCT03011749
What this trial is testing

Value of FLT PET/CT in Radium-223 Therapy of mCRPC Patients

Who this might be right for
Metastatic Prostate Carcinoma
Rigshospitalet, Denmark 6
Early research (Phase 1)WithdrawnNCT02866916
What this trial is testing

Study of SXL01 in Patients With Metastatic Castration-Resistant Prostate Cancer (PROSTIRNA)

Who this might be right for
Prostatic Cancer, Castration-Resistant
Institut Claudius Regaud
Not applicableWithdrawnNCT02130947
What this trial is testing

Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05113537
What this trial is testing

Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+4 more
Vadim S Koshkin 30
Testing effectiveness (Phase 2)Study completedNCT04564027
What this trial is testing

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

Who this might be right for
Advanced Solid Tumours
AstraZeneca 54
Testing effectiveness (Phase 2)WithdrawnNCT07025512
What this trial is testing

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

Who this might be right for
Metastatic Castration Resistant Prostate CancerCytopeniaAnemia+1 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00291005
What this trial is testing

PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone

Who this might be right for
Prostatic Neoplasms
Sanofi 42
Not applicableStudy completedNCT02803437
What this trial is testing

Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Bayer 334
Testing effectiveness (Phase 2)Study completedNCT01338792
What this trial is testing

Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-resistant Prostate CancerRecurrent Prostate Cancer
University of Southern California 47
Testing effectiveness (Phase 2)Ended earlyNCT02933801
What this trial is testing

ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.

Who this might be right for
Prostate Cancer MetastaticProstate Cancer
Swiss Cancer Institute 92
Testing effectiveness (Phase 2)Active Not RecruitingNCT04777071
What this trial is testing

An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma+3 more
University of Washington 141
Early research (Phase 1)Study completedNCT00872157
What this trial is testing

BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT00448409
What this trial is testing

Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 27
Next Page